Misplaced Pages

Tetroxoprim

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is the current revision of this page, as edited by Entranced98 (talk | contribs) at 20:29, 29 January 2023 (Importing Wikidata short description: "Chemical compound"). The present address (URL) is a permanent link to this version.

Revision as of 20:29, 29 January 2023 by Entranced98 (talk | contribs) (Importing Wikidata short description: "Chemical compound")(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Tetroxoprim" – news · newspapers · books · scholar · JSTOR (August 2014) (Learn how and when to remove this message)
Pharmaceutical compound
Tetroxoprim
Clinical data
ATC code
Identifiers
IUPAC name
  • 5-pyrimidine-2,4-diamine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.053.427 Edit this at Wikidata
Chemical and physical data
FormulaC16H22N4O4
Molar mass334.376 g·mol
3D model (JSmol)
SMILES
  • COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
InChI
  • InChI=1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20)
  • Key:WSWJIZXMAUYHOE-UHFFFAOYSA-N
  (what is this?)  (verify)

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.

Its chemical formula is C=16 | H=22 | N=4 | O=4.

References

  1. Aschhoff HS, Vergin H (November 1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother. 5 (B): 19–25. doi:10.1093/jac/5.supplement_b.19. PMID 43863.
  2. ^ "Tetroxoprim". pubchem.ncbi.nlm.nih.gov.
  3. ^ "Tetroxoprim - an overview | ScienceDirect Topics". www.sciencedirect.com.
Antibacterials that inhibit nucleic acid (J01E, J01M)
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins


Stub icon

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: